Company
Nano-X Imaging Ltd.
Headquarters: Neve Ilan, Israel
Employees: 50
Market Cap
$339.5 Million
USD as of July 1, 2025
Nano-X Imaging Ltd. Categories
Israel Healthcare Medical DevicesIsrael Healthcare Israel Medical Devices
Top Competitors by Market Capitalization
Industry: Medical Devices
| Company | Market Cap (USD) |
|---|---|
| Abbott | $233.33 B |
| Boston Scientific Corporation | $154.34 B |
| Stryker | $151.06 B |
| Medtronic | $113.25 B |
| Edwards Lifesciences Corporation | $45.05 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $699.59 B |
| Johnson & Johnson | $374.29 B |
| AbbVie | $336.94 B |
| Novo Nordisk | $309.91 B |
| UnitedHealth Group | $279.90 B |
Detailed Description
Nano-X Imaging Ltd., a development-stage company, develops, produces, and commercializes digital X-ray source technology for the medical imaging industry worldwide. Its X-ray source is based on a novel digital MEMs semiconductor cathode. The company also develops a prototype of the Nanox.ARC, a medical imaging system incorporating its novel digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that will allow for the delivery of medical screening as a service. Nano-X Imaging Ltd. was founded in 2011 and is headquartered in Neve Ilan, Israel.
Financials
| Last Financial Reports Date | Dec. 31, 2023 |
| Revenue TTM | $9.9 M |
| EBITDA | $-47,693,000 |
| Gross Profit TTM | $-6,592,000 |
| Profit Margin | -66.55% |
| Operating Margin | -438.67% |
| Quarterly Revenue Growth | 12.40% |
Stocks & Indices
Nano-X Imaging Ltd. has the following listings and related stock indices.
Stock: NASDAQ: NNOX wb_incandescent